NCT03769870

Teneligliptin and Atorvastatin DDI Study

A Randomized, Open-label, Cross-over, Multiple Dosing Study to Evaluate Drug-drug Interaction Between Teneligliptin and Atorvastatin in Healthy Male Adults

• Status: Completed
• Phase: Phase 1
• Study type: Interventional
• Enrollment: 30 (actual)
• Sponsor: Handok Inc. · Industry
• Sex: Male
• Age: 19 Years – 45 Years
• Healthy volunteers: Accepted

Summary

A randomized, open-label, cross-over, multiple dosing study to evaluate drug-drug interaction between Teneligliptin and Atorvastatin in healthy male adults

Conditions

• Diabete Mellitus

Interventions

Type	Name	Description
DRUG	Teneligliptin 20mg/day	cross-over
DRUG	Atorvastatin 40mg/Day	cross-over
DRUG	Teneligliptin 20mg/day + Atorvastatin 40mg/day	cross-over

Timeline

• Start date: 2019-01-11
• Primary completion: 2019-02-25
• Completion: 2019-02-25
• First posted: 2018-12-10
• Last updated: 2019-05-30

Locations

1 site across 1 country: South Korea